Healthcare Innovation December 3, 2025
The recent negotiations have expanded Medicare’s drug price controls to 25 medications
Last week, the Centers for Medicare & Medicaid Services (CMS) announced a net savings of 44 percent, or $12 billion, from last year’s negotiated Medicare spending on 15 drugs widely used to treat cancer and other severe chronic conditions.
According to a press release, the Maximum Fair Prices (MFPs) for these 15 drugs will go into effect on January 1, 2027, bringing the total number of negotiated drugs to 25 when combined with the 10 drugs negotiated earlier, with MFPs taking effect on January 1, 2026. The 15 drugs in this second negotiation cycle, used to treat cancer, diabetes, asthma, and other chronic illnesses,...
Today's Sponsors
Today's Sponsor
Topics: Biotechnology, CMS, Govt Agencies, Insurance, Medicare, Patient / Consumer, Pharma, Pharma / Biotech